Regulation and mechanisms of macrophage cholesterol efflux

Journal of Clinical Investigation

Volumn 110, Issue 7, 2002, Pages 899-904

  Tall, Alan R ^a   Costet, Philippe ^a   Wang, Nan ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; CHOLESTEROL; CYCLIC AMP; HIGH DENSITY LIPOPROTEIN; MESSENGER RNA; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; TRANSCRIPTION FACTOR LXR; TRANSCRIPTION FACTOR RXR; UNCLASSIFIED DRUG;

ATHEROGENESIS; CELL MEMBRANE TRANSPORT; FATTY ACID SYNTHESIS; GENE EXPRESSION REGULATION; HUMAN; LIVER METABOLISM; MACROPHAGE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LIPID INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSPORT KINETICS;

EID: 0036790522     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0216391     Document Type: Review

References (49)

1. Williams, K.J., and Tabas, I. 1998. The response-to-retention hypothesis of atherogenesis reinforced. Curr. Opin. Lipidol. 9:471-474.
2. Oram, J.F., Albers, J.J., Cheung, M.C., and Bierman, E.L. 1981. The effects of subfractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts. Regulation of low density lipoprotein receptor activity. J. Biol. Chem. 256:8348-8356.
3. Hara, H., and Yokoyama, S. 1991. Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. J. Biol. Chem. 266:3080-3086.
4. Rubin, E.M., Krauss, R.M., Spangler, E.A., Verstuyft, J.G., and Clift, S.M. 1991. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature. 353:265-267.
5. Plump, A.S., Scott, C.J., and Breslow, J.L. 1994. Human apolipoprotein A·I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA. 91:9607-9611.
6. Francis, G.A., Knopp, R.H., and Oram, J.F. 1995. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J. Clin. Invest. 96:78-87.
7. Lawn, R.M., Wade, D.P., Couse, T.L., and Wilcox, J.N. 2001. Localization of human ATP-binding cassette transporter 1(ABC1) in normal and atherosclerotic tissues. Arterioscler. Thromb. Vasc. Biol. 21:378-385.
8. Langmann, T., et al. 1999. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Commun. 257:29-33.
9. Fu, X., et al. 2001. 27-Hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J. Biol. Chem. 276:38378-38387.
10. Björkhem, I. 2002. Do oxysterols control cholesterol homeostasis? J. Clin. Invest. 110:725-730. doi: 10.1172/JCI200216388.
11. Gan, X., et al. 2001. Dual mechanisms of ABCA1 regulation by geranylgeranyl pyrophosphate. J. Biol. Chem. 276:48702-48708.
12. Lin, G., and Bornfeldt, K.E. 2002. Cyclic AMP-specific phosphodiesterase 4 inhibitors promote ABCA1 expression and cholesterol efflux. Biochem. Biophys. Res. Commun. 290:663-669.
13. Panousis, C.G., and Zuckerman, S.H. 2000. Interferon-gamma induces downregulation of Tangier disease gene (ATP-binding-cassette transporter 1) in macrophage-derived foam cells. Arterioscler. Thromb. Vasc. Biol. 20:1565-1571.
14. Chawla, A., et al. 2001. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell. 7:161-171.
15. Akiyama, T.E., et al. 2002. Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Mol. Cell. Biol. 22:2607-2619.
16. Claudel, T., et al. 2001. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. Proc. Natl. Acad. Sci. USA. 98:2610-2615.
17. Oliver, W.R., Jr., et al. 2001. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc. Natl. Acad. Sci. USA. 98:5306-5311.
18. Ou, J., et al. 2001. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc. Natl. Acad. Sci. USA. 98:6027-6032.
19. Wang, Y., and Oram, J.F. 2002. Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1. J. Biol. Chem. 277:5692-5697.
20. Arakawa, R., and Yokoyama, S. 2002. Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation. J. Biol. Chem. 277:22426-22429.
21. Rothblat, G.H., et al. 1999. Cell cholesterol efflux: integration of old and new observations provides new insights. J. Lipid Res. 40:781-796.
22. Acton, S., et al. 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271:518-520.
23. Ji, Y., et al. 1997. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272:20982-20985.
24. Gu, X., Kozarsky, K., and Krieger, M. 2000. Scavenger receptor class B, type I-mediated [3H]cholesterol efflux to high and low density lipoproreins is dependent on lipoprotein binding to the receptor. J. Biol. Chem. 275:29993-30001.
25. Wang, N., Silver, D.L., Costet, P., and Tall, A.R. 2000. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J. Biol. Chem. 275:33053-33058.
26. Phillips, M.C., Johnson, W.J., and Rothblat, G.H. 1987. Mechanisms and consequences of cellular cholesterol exchange and transfer. Biochim. Biophys. Acta. 906:223-276.
27. Liadaki, K.N., et al. 2000. Binding of high density lipoprotein (HDL) and discoidal reconstituted HDL to the HDL receptor scavenger receptor class B type I. Effect of lipid association and APOA-I mutations on receptor binding. J. Biol. Chem. 275:21262-21271.
28. Wang, N., Silver, D.L., Thiele, C., and Tall, A.R. 2001. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J. Biol. Chem. 276:23742-23747.
29. Fielding, C.J., and Fielding, P.E. 2001. Cellular cholesterol efflux. Biochim. Biophys. Acta. 1533:175-189.
30. Bungert, S., Molday, L.L., and Molday, R.S. 2001. Membrane topology of the ATP binding cassette transporter ABCR and its relationship to ABC1 and related ABCA transporters: identification of N-linked glycosylation sites. J. Biol. Chem. 276:23539-23546.
31. Remaley, A.T., et al. 2001. Apolipoprotein specificity for lipid efflux by the human ABCA1 transporter. Biochem. Biophys. Res. Commun. 280:818-823.
32. Oram, J.F., Lawn, R.M., Garvin, M.R., and Wade, D.P. 2000. ABCA1 is the cAMP-inducible apolipoprorein receptor that mediates cholesterol secretion from macrophages. J. Biol. Chem. 275:34508-34511.
33. Fitzgerald, M.L., et al. 2002. Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-I. J. Biol. Chem. 277:33178-33187.
34. Chambenoit, O., et al. 2001. Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter. J. Biol. Chem. 276:9955-9960.
35. Neufeld, E.B., et al. 2001. Cellular localization and trafficking of the human ABCA1 transporter. J. Biol. Chem. 276:27584-27590.
36. Takahashi, Y., and Smith, J.D. 1999. Cholesterol efflux to apolipoprorein A1 involves endocytosis and resecretion in a calcium-dependent pathway. Proc. Natl. Acad. Sci. USA. 96:11358-11363.
37. Chen, W., et al. 2001. Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late endosomes/lysosomes. J. Biol. Chem. 276:43564-43569.
38. Leventhal, A.R., Chen, W., Tall, A.R., and Tabas, I. 2001. Acid sphingomyelinase-deficient macrophages have defective cholesterol trafficking and efflux. J. Biol. Chem. 276:44976-44983.
39. Aiello, R.J., et al. 2002. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Artorioscler. Thromb. Vasc. Biol. 22:630-637.
40. van Eck, M., et al. 2002. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc. Natl. Acad. Sci. USA. 99:6298-6303.
41. Cavelier, L.B., et al. 2001. Regulation and activity of the human ABCA1 gene in transgenic mice. J. Biol. Chem. 276:18046-18051.
42. Joyce, C.W., et al. 2002. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proc. Natl. Acad. Sci. USA. 99:407-412.
43. Singaraja, R.R., et al. 2002. Increased ABCA1 activity protects against atherosclerosis. J. Clin. Invest. 110:35-42. doi:10.1172/JCI200215748.
44. Joseph, S.B., et al. 2002. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc. Natl. Acad. Sci. USA. 99:7604-7609.
45. Schaefer, E.J., Zech, L.A., Schwartz, D.E., and Brewer, H.B., Jr. 1980. Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease). Ann. Intern. Med. 93:261-266.
46. van Dam, M.J., et al. 2002. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study. Lancet 359:37-42.
47. Bellosta, S., et al. 1995. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J. Clin. Invest. 96:2170-2179.
48. Repa, J.J., et al 2000. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 14:2819-2830.
49. Fitzgerald, M.L., et al. 2001. ATP-binding cassette transporter A1 contains an NH2-terminal signal anchor sequence that translocates the protein's first hydrophilic domain to the exoplasmic space. J. Biol. Chem. 276:15137-15145.